Temporarily Closed. New orders are paused while we resolve an unforeseen operational issue. Existing orders will still be fulfilled.

Thymosin Alpha 1

Accelerating

Thymosin Alpha 1 appears in 1,070 indexed publications going back to 1978, including 22 in the past twelve months. 31 registered trials appear on ClinicalTrials.gov.

1,070
Indexed publications
22
Past 12 months, against 15 the year before
31
Registered clinical trials
47
Monthly readers on Wikipedia, up 2%
Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
201529
201612
201712
201826
201912
202025
202116
202217
202330
202413
202516
202618
Public Attention

Who is looking it up

Monthly readers of the Thymosin Alpha 1 article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-122026-08
Clinical Trials

The registered pipeline

Early Phase 1
0
Phase 1
3
Phase 2
9
Phase 3
3
Phase 4
4

Phase distribution across the most recently updated registered trials.

References

Most recent work

The newest indexed records mentioning Thymosin Alpha 1, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

  1. 2026-03-23·Virulence

    Thymosin α1-induced secretion of the IL-15/RA complex by THP-1-derived dendritic cells restrains HIV latency <i>in vitro</i>

    Chen C, Xun J, Wang J et al.

  2. 2026-09-09·The Cochrane database of systematic reviews

    Thymosin-ɑ1 for people with chronic hepatitis B

    Naing C, Ni H, Aung HH et al.

  3. 2026-05-28·Journal of traditional and complementary medicine

    A prospective clinical study on the effectiveness of <i>Phellinus igniarius</i> decoction in treating immune dysfunction in colorectal cancer patients following chemfotherapy

    Zhang H, Li W, Hu D et al.

  4. 2026-09-03·Advanced science (Weinheim, Baden-Wurttemberg, Germany)

    Thymosin Alpha-1 Provides Direct Neuroprotection by Engaging the Orexin Receptor HCRTR1 to Suppress Neuronal Necroptosis

    Kang X, Wang S, Zhang L et al.

  5. 2026-09-01·Cancer research

    Thymosin Alpha-1 Restores Chemotherapy-Induced Antitumor Immunity by Chaperoning a MicroRNA Ligand of TLR7 in Dendritic Cells

    Wei Y, Chen J, Zhang Y et al.

  6. 2026-05-29·Journal of gastroenterology and hepatology

    Regarding IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8+ T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression

    Sengul I, Sengul D. et al.

  7. 2026-06-01·Asian Pacific journal of cancer prevention : APJCP

    Thymosin α1 Augments CD8⁺ T-Cell Activation and Reverses Exhaustion In Vitro

    Mishra S, Telang G, Sureshbabu A et al.

  8. 2026-03-26·Journal of gastroenterology and hepatology

    IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8<sup>+</sup> T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression

    Wu F, Guo Z, Guan J et al.

In the Catalogue

Thymosin Alpha 1 available from Polaris Research

Supplied as research materials for laboratory use. Free express delivery Australia wide.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-09-13.